NewLink Genetics Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.
“A number of laboratories around the word have found this basic science, immuno-therapy, (to be) working really well in animal models and those antibodies were made into drugs that could be used in humans.” Read the following article
NewLink Genetics Corp. is a clinical stage immuno-oncology company, which focuses on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Its portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. The company’s products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189 and IDO Pathway Inhibitors. NewLink Genetics was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. [Source: MarketWatch]
Company Website: http://www.newlinkgenetics.com